Last reviewed · How we verify
Progressive Diffuse Large B-Cell Lymphoma
Approved treatments
- Decadron · Generic (originally Merck)
- Medrol · Generic (originally Upjohn/Pfizer)
Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions. - Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
- Methylprednisolon · Leiden University Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Progressive Diffuse Large B-Cell Lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Progressive Diffuse Large B-Cell Lymphoma treatment landscape brief
- Progressive Diffuse Large B-Cell Lymphoma treatment updates RSS
Frequently asked questions about Progressive Diffuse Large B-Cell Lymphoma
What drugs treat Progressive Diffuse Large B-Cell Lymphoma?
Tracked treatments include Decadron, Medrol, Prelone, prednisolon, Methylprednisolon.
What is the treatment for Progressive Diffuse Large B-Cell Lymphoma?
Standard treatment for Progressive Diffuse Large B-Cell Lymphoma includes Decadron, Medrol, Prelone, prednisolon, Methylprednisolon. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Progressive Diffuse Large B-Cell Lymphoma patent cliff · Progressive Diffuse Large B-Cell Lymphoma CI report
- Treatment: Decadron · Generic (originally Merck)
- Treatment: Medrol · Generic (originally Upjohn/Pfizer)
- Treatment: Prelone · Generic (originally Schering)
- Treatment: prednisolon · Hannover Medical School
- Treatment: Methylprednisolon · Leiden University Medical Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing